These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 33322962)

  • 41. Current and emerging pharmacotherapies for treating tobacco dependence.
    Schnoll RA; Lerman C
    Expert Opin Emerg Drugs; 2006 Sep; 11(3):429-44. PubMed ID: 16939383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-nicotinic therapies for smoking cessation.
    Siu EC; Tyndale RF
    Annu Rev Pharmacol Toxicol; 2007; 47():541-64. PubMed ID: 17209799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular genetics of successful smoking cessation: convergent genome-wide association study results.
    Uhl GR; Liu QR; Drgon T; Johnson C; Walther D; Rose JE; David SP; Niaura R; Lerman C
    Arch Gen Psychiatry; 2008 Jun; 65(6):683-93. PubMed ID: 18519826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nicotine receptor partial agonists for smoking cessation.
    Livingstone-Banks J; Fanshawe TR; Thomas KH; Theodoulou A; Hajizadeh A; Hartman L; Lindson N
    Cochrane Database Syst Rev; 2023 May; 5(5):CD006103. PubMed ID: 37142273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.
    Eisenberg MJ; Filion KB; Yavin D; Bélisle P; Mottillo S; Joseph L; Gervais A; O'Loughlin J; Paradis G; Rinfret S; Pilote L
    CMAJ; 2008 Jul; 179(2):135-44. PubMed ID: 18625984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.
    Kaufmann A; Hitsman B; Goelz PM; Veluz-Wilkins A; Blazekovic S; Powers L; Leone FT; Gariti P; Tyndale RF; Schnoll RA
    Addict Behav; 2015 Dec; 51():93-9. PubMed ID: 26240944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.
    Kozak K; George TP
    Expert Opin Pharmacother; 2020 Apr; 21(5):581-590. PubMed ID: 32011186
    [No Abstract]   [Full Text] [Related]  

  • 49. Antidepressants for smoking cessation.
    Howes S; Hartmann-Boyce J; Livingstone-Banks J; Hong B; Lindson N
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD000031. PubMed ID: 32319681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
    Keating GM; Lyseng-Williamson KA
    Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Medical therapy for smoking cessation].
    Zeller A
    Ther Umsch; 2010 Aug; 67(8):419-25. PubMed ID: 20687045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
    Rose JE; Behm FM; Drgon T; Johnson C; Uhl GR
    Mol Med; 2010; 16(7-8):247-53. PubMed ID: 20379614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment.
    Russo P; Cesario A; Rutella S; Veronesi G; Spaggiari L; Galetta D; Margaritora S; Granone P; Greenberg DS
    Curr Med Chem; 2011; 18(1):91-112. PubMed ID: 21110812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interventions for smoking cessation and reduction in individuals with schizophrenia.
    Tsoi DT; Porwal M; Webster AC
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD007253. PubMed ID: 23450574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice.
    Giulietti F; Filipponi A; Rosettani G; Giordano P; Iacoacci C; Spannella F; Sarzani R
    High Blood Press Cardiovasc Prev; 2020 Oct; 27(5):349-362. PubMed ID: 32578165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interventions for preventing weight gain after smoking cessation.
    Parsons AC; Shraim M; Inglis J; Aveyard P; Hajek P
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006219. PubMed ID: 19160269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions.
    Siegel SD; Lerman C; Flitter A; Schnoll RA
    Cancer Prev Res (Phila); 2020 Mar; 13(3):261-272. PubMed ID: 32132120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews.
    Hartmann-Boyce J; Stead LF; Cahill K; Lancaster T
    Addiction; 2014 Sep; 109(9):1414-25. PubMed ID: 24995905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Varenicline versus nicotine replacement therapy for long-term smoking cessation: an observational study using the Clinical Practice Research Datalink.
    Davies NM; Taylor AE; Taylor GM; Itani T; Jones T; Martin RM; Munafò MR; Windmeijer F; Thomas KH
    Health Technol Assess; 2020 Feb; 24(9):1-46. PubMed ID: 32079557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adapting smoking cessation treatment according to initial response to precessation nicotine patch.
    Rose JE; Behm FM
    Am J Psychiatry; 2013 Aug; 170(8):860-7. PubMed ID: 23640009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.